Dexmethylphenidate hydrochloride is under clinical development by Cingulate and currently in Phase III for Attention Deficit Hyperactivity Disorder (ADHD). According to GlobalData, Phase III drugs for ...

H.C. Wainwright lifted its price target on shares of Cingulate (NASDAQ: CING) to $20.00, a significant increase from the previous target of $8.00. The firm has maintained a Buy rating on the stock, ...

Compare Dexedrine and Adderall here. Focalin is the brand name for dexmethylphenidate, another CNS stimulant. This drug comes in IR and XR forms. A person may need to take two doses 4 hours apart ...

What Is ADHD (Attention Deficit Hyperactivity Disorder)? Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed neurological condition. It affects more than 8% of children and 2.5% of ...